Alyeska Investment Group »

Aura Biosciences shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $673k 76k 8.86
2022-12-31 $225k 22k 10.50

More positions owned by Alyeska Investment Group

Meta Platforms Cl A (META)
Aercap Holdings Nv SHS (AER)
Take-Two Interactive Software (TTWO)
Epam Systems (EPAM)
Dollar General (DG)
Paycom Software (PAYC)
Twilio Cl A (TWLO)
Burlington Stores (BURL)
Lauder Estee Cos Cl A (EL)
Adobe Systems Incorporated (ADBE)
Oracle Corporation (ORCL)
Autodesk (ADSK)
Xylem (XYL)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Amazon (AMZN)

View all positions for Alyeska Investment Group

Top funds holding Aura Biosciences

Eventide Asset Management
Citadel Advisors
Medicxi Ventures Management
Vanguard Group
Nantahala Capital Management
Goldman Sachs Group
Regency Capital Management
T. Rowe Price Associates
Franklin Resources
Decheng Capital
Long Focus Capital Management
Monashee Investment Management
Dimensional Fund Advisors
TD Asset Management
Levin Capital Strategies

View all funds holding Aura Biosciences